Kareem Hubbard, M.D.; Decision and Order discussed on April 11 by Justice Department

Webp 18edited

Kareem Hubbard, M.D.; Decision and Order discussed on April 11 by Justice Department

The US Justice Department published a one page notice on April 11, according to the U.S. Government Publishing Office.

The notice is focused on Kareem Hubbard, M.D.; Decision and Order.

The Department is one of the oldest in the US, focused primarily on law enforcement and the federal prison system. Downsizing the Federal Government, a project aimed at lowering taxes and boosting federal efficiency, detailed wasteful expenses such as $16 muffins at conferences and board meetings.

Notices are required documents detailing rules and regulations being proposed by each federal department. This allows the public to see what issues legislators and federal departments are focusing on.

Any person or organization can comment on the proposed rules. Departments and agencies must then address “significant issues raised in comments and discuss any changes made,” the Federal Register says.

Notices published by the Justice Department on April 11

Title
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
Requiring Online Submission of Applications for and Renewals of DEA Registration
Crosby Pharmacy and Wellness; Decision and Order
Douglas A. Blose, M.D.; Decision and Order
Noah David, P.A.; Decision and Order
Craig S. Rosenblum, M.D.; Decision and Order
Christopher King, C.N.P.; Decision and Order
Kareem Hubbard, M.D.; Decision and Order
Kirk A. Hopkins, M.D.; Decision and Order
George Pharmacy, Inc.; Decision and Order
Gilbert Y. Kim, D.D.S.; Decision and Order
David H. Betat, M.D.; Decision and Order
Jennifer Smith, M.D.; Decision and Order
Adam T. Rodman, P.A.; Decision and Order
Lezlie McKenzie, N.P.; Decision and Order
OakmontScript Limited Partnership; Decision and Order

More News